Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-19
    E.g., 2018-08-19

Archive Search

1 results
12:00 AM, Apr 12, 2010  |  BC Week In Review | Company News  |  Deals

Altheos, Asahi Kasei Pharma deal

Asahi Kasei granted Altheos exclusive, worldwide rights, excluding Japan and Korea, to develop and commercialize ATS907
for all indications. ATS907, a Rho kinase inhibitor, is in preclinical development to treat glaucoma. The …